EFFECTS OF SELENIUM SUPPLEMENTATION ON APOLIPOPROTEINS AND LIPID PROFILE IN STEADY-STATE SICKLE CELL DISEASE PATIENTS IN SOUTHEASTERN NIGERIA
DOI:
https://doi.org/10.61841/531mc489Keywords:
HDL-C High density lipoprotein-cholesterol, LDL-C low density lipoprotein-cholesterol, Se Selenium, TC Total cholesterol, TG Triglyceride, VLDL-C Very low density lipoprotein cholesterol, Apo A-1 Apolipoprotein A-1, Apo B Apolipoprotein B, SS Homozygous sickle cell hemoglobin, AA Homozygous Adult hemoglobin, AS Heterozygous sickle disease carrier hemoglobinAbstract
Sickle Cell Disease (SCD) is the most prevalent hereditary hemoglobinopathy characterized by chronic oxidative stress, inflammation and metabolic disturbances that causes long-term disability requiring daily care. Sickle cell disease affects about 4.4 million people globally. Selenium (Se), an essential micronutrient with antioxidant properties, may influence oxidative balance and lipid metabolism in SCD. However, there is paucity of data, especially in sub-Saharan Africa, on the effect of Se supplementation on apolipoproteins and lipid profile in SCD. This study assessed the effect of Se supplementation on levels of serum Se, apolipoproteins A1 and B (apo A1 and apo B), and other lipid profile markers among individuals with different HB genotype blood groups. One hundred and fifty (150) aged-matched adult (18-60years) attending routine clinic in the Hematology department of the Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria, were randomly recruited and grouped according to hemoglobin genotype: group 1= HbAA (n=50), group 2= HbAS (n=50) and group 3= HbSS (n=50). Participants in group 3 received oral Se supplementation (200 µg/day) for 90 days. Blood samples were collected at baseline and after 90 days (post supplementation). Serum Se was measured using atomic absorption spectrophotometry method (AAS) while apolipoproteins and lipid profile were determined using enzymatic spectrophotometric method. Questionnaires were administered to participants for relevant data. At baseline, the study showed that there were significant variations in the levels of apo A1, Apo B, TG, HDL-C, LDL-C and VLDL-C concentrations among the three groups (p< 0.001). However, after Se supplementation in the HbSS group, apo A1 and B levels increased significantly (p= 0.003 and 0.001, respectively). Likewise, HDL-C and TG concentrations were significantly elevated (p < 0.001), whereas total cholesterol and LDL-C levels showed no significant changes post-supplementation. The findings from this study suggest that dyslipidemia and oxidative stress persist in steady-state SCD. Low level of Se is indicative of a weakened antioxidant defense even in individuals with steady-state SCD. Selenium supplementation in SCD patients in this study appears to improve selected lipid and apolipoprotein parameters, suggesting its potential therapeutic value in the management of SCD.
References
Bismal Rizwan S, Pals Sabnams, Parida P, Pal A (2019). Oxidative stress, antioxidant capacity and inflammation symptoms of SCD. Hematology. 24: 1-9
Cabana VG, Reardon CA, Wei B, Lukens JR. Getz GS (2019). SAA only HDL formed during the acute phase response in apo A-1 and apo A-1 mice. Journal of lipid resource. 40 (6): 1090-1030.
Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS (2023). Serum paraxonase: effect of the apolipoprotein composition of HDL and the acute phase response. Journal of lipid resource. 44(4) 780-792.
Gallaway P, Miyake H, Buchowski M, Shimada M, Yoshitake Y, Kim A et al., (2017) Physical activity a viable way to reduce the risks of mild cognitive impairment, Alzheimer's disease and vascular dementia in older adults. Brain Sciences 7, article 22.
Feugrey G, Dumesnilic Grall M, Benhamou Y, Girot H, Fettig J et al., (2023). LDH and hemolysis index to predict VOC in SCD. Science Research. 13:21198.
Feugrey G, Maximillien G, Cecille D, Valery B, Ygal B, Muriel Q, Muraine and Paul Billoir (2024). Lipids in health and disease. 23:140.
Ji Ming Wang, Keqiang Chen (2019). Biomarkers of CVD. Biologically active.
Lalanne-Mistrih ML, Connes P, Lamarre Y, Lemonne N, Hardy- Dessources MD, Tarer V, Etienne —Julan M, Mougenel D, Tressieres B, Rommana M (2018). Lipid Profiles in French west indies sickle cell disease cohorts and their general population. Lipids Health Disease. 17:38.
Lalanne-Dessources MD, TarerV, Etienne-Julan M, Mougenel D, Tressieres B, Romana M (2018). Lipid profiles in West Indies Sickle cell disease cohorts and their general population. Lipids Health Disease.
Natta CL. Chen LC, Chow CK (1990). Selenium and glutathione peroxidase levels in SCA. Acta Haematology. 83: 130-132.
Proteasa EA lonescu I (2022). Fatty acid peroxidation in relation to trace elements in serum of patients with homozygous SCA and ß thalassaemias a gas chromatographic study. Nutrients. 11(5):450-546.
Shao B, Heinecke JW (2009). HDL Lipid peroxidation and atherosclerosis. Journal of Lipid Resources. 50:599-601
Tshilolo L, Tomlinson G. Williams T N et al (2019). Hydroxyurea for children with sickle cell anaemia in Sub-Saharan Africa. National England Journal ofMedicine. 380 (2): 121-131
Westerman MP Hypocholesterolemia and anaemia. British Journal ofHaematology (1975): 31:87-94
Yalcinkaya A, Samadi A, Lay I, Unal S, Sabuncuoglu S,Oztas Y (2019). Oxysterol concentrations are associated with cholesterol concentrations and anemia in paediatric patients with sickle cell disease. Scand Journal of Chnica/ Laboratory investigation. 1 : 1-7.
Oluwadamilola AD, Akinremi T I, Adefisan MA, Olayiwola SD (2021). Knowledge, attitude and control practices of sickle cell disease among senior secondary students in Osun State Nigeria. PanAfrican Medical Journal. 38:350.
Hebbel RR Eaton JW, Balasingam M, Steinberg MH (2022). Spontaneous oxygen radical generation by sickle erythrocytes. Journal ofclinical investigation. 70: 1253-1259.
Hosoal H, Webb NR, Glick JM, Tietge IJJ, Purdom MS, de BEER fc et al (1999). Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL-C or apo A-I levels in human apo A-I transgenic mice. Journal of lipid resource. 40 (4): 648-653.
Delesderrier E, Claudia S-Cople Rodrigues, Julliana O Marcos K E Flavia 8B, Adriana CBI Josley CK, El-Ghamrawy MK, Hanna WM. Abdelsalam A, El-Sonbaty MM, Adel A, ER Y (2019). Oxidant-antioxidant status in Egyptian children with sickle cell anaemia A single centre-based study. Journal ofPaediatric. 90(3):286-292.
Kambali-Kombi R Marini Djang'eing' RjAlworong ra Opara JR Tonen-Woylec S, Kayembe Kambali-Kombi R Marini Djang'eing r R, Alworong la Opara JP et al., (2021). Management of sickle cell disease current practices and challenges in North-Eastern region of the Democratic Republic of Congo. Haematology. 26 (1): 199-205.
Yuditskaya S, Tumblin A Hoetin GT. Wang G, Drake SK, XuX (2009). Proteomic identification of altered lipoproteins patterns in pulmonary hypertension and vasculopathy of SCD. Blood. 1 13(5): 1 122-1 128.
Rees DC, Williams TN, Gladwin MT (2010). Sickle cell disease. Lancet 376 (9757): 2018-2031.
Booth C, Inusa B, Obaro SK (2010). Infection in Sickle cell disease a review International Journal of Infectious diseases. 14 (1): 2-12.
Ahmet et al (2019). Association of T NF —aj Apolipoproteinsjbilirubin and uric acid. Lipids in health and diseases. 1 8: 225: 1075.
Ezenwosu OIJ, Chukwu BF, Ezenwosu Il-j Ikemefuna AN, Emodi IJ, Ezeanolue EE (2020). Knowledge and awareness of individual sickle cell genotype among adolescents in a unity secondary in South East Nigeria a cross-sectional study. International Journal of Adolescent Medical Health. 20190149.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
